Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies

INTRODUCTION: The impact of preformed donor-specific anti–human leukocyte antigen (HLA) antibodies (pDSAs) after combined liver-kidney transplantation (CLKT) is still uncertain. METHODS: We conducted a retrospective study in 8 European high-volume transplant centers and investigated the outcome of 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Bello, Arnaud, Thaunat, Olivier, Le Quintrec, Moglie, Bestard, Oriol, Durrbach, Antoine, Perrin, Peggy, Gatault, Philippe, Jambon, Frederic, Pageaux, Georges-Philippe, Llado, Laura, Besch, Camille, Barbier, Louise, Neau-Cransac, Martine, Dumortier, Jérôme, Kamar, Nassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710847/
https://www.ncbi.nlm.nih.gov/pubmed/33305113
http://dx.doi.org/10.1016/j.ekir.2020.09.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710847/
https://www.ncbi.nlm.nih.gov/pubmed/33305113
http://dx.doi.org/10.1016/j.ekir.2020.09.018

Ejemplares similares